CMV (DNA detection by Real time PCR CSF)

Blood

Report in 264Hrs

At Home

No Fasting Required

Details

Detects CMV DNA in CSF.

₹6,845₹9,779

30% OFF

CMV (DNA detection by Real time PCR CSF) - Comprehensive Medical Test Information Guide

1. Why is it done?
- Test Description: This test detects Cytomegalovirus (CMV) DNA in cerebrospinal fluid (CSF) using real-time polymerase chain reaction (PCR), a highly sensitive molecular technique that amplifies and identifies viral genetic material directly from the fluid surrounding the brain and spinal cord.
- Primary Indications: Suspected CMV meningitis or encephalitis, particularly in immunocompromised patients (HIV/AIDS with CD4 count <50 cells/µL, organ transplant recipients, patients on immunosuppressive therapy); evaluation of central nervous system infections with typical CMV symptoms; assessment of patients with unexplained neurological symptoms and risk factors for CMV.
- Typical Clinical Scenarios: When patients present with fever, headache, altered mental status, seizures, or neurological deficits; during routine CNS infection workup in severely immunocompromised individuals; when other viral causes have been excluded; and in cases of ventriculoencephalitis or polyradiculomyelitis.
2. Normal Range
- Normal Result: NEGATIVE or UNDETECTED - CMV DNA is not detected in the cerebrospinal fluid sample
- Units of Measurement: Copies per milliliter (copies/mL) or International Units per milliliter (IU/mL); quantitative results expressed as viral load
- Reference Range Interpretation: Less than the limit of detection (typically <500 copies/mL or <200 copies/mL depending on laboratory assay sensitivity); results below this threshold are considered negative
- What Normal Means: No active CMV infection in the central nervous system; absence of CMV meningitis or encephalitis; effectively rules out CMV as the cause of current CNS symptoms in most clinical contexts
- What Abnormal Means: POSITIVE result indicates active CMV replication in the cerebrospinal fluid, confirming diagnosis of CMV meningitis, encephalitis, or other CNS CMV infection; quantitative values help assess disease burden and treatment response
3. Interpretation
- NEGATIVE/UNDETECTABLE Result: CMV is not the cause of current neurological symptoms; however, does not completely rule out past exposure or seropositivity; in immunocompromised patients with typical CMV presentation, negative result suggests need to investigate alternative diagnoses or consider timing of sampling early in infection
- POSITIVE Result (Low Level - <1,000 copies/mL): Indicates CMV DNA presence in CSF; clinically significant especially in symptomatic immunocompromised patients; confirms active CNS infection; treatment is typically warranted; clinical correlation with symptoms and CSF parameters (cell count, protein, glucose) is essential
- POSITIVE Result (Moderate to High Level - >1,000 copies/mL): Indicates substantial CMV viral replication in CNS; strong evidence of active CMV meningitis or encephalitis; higher viral load correlates with more aggressive disease; immediate antimicrobial therapy is indicated; close monitoring and repeat CSF testing may be warranted
- Factors Affecting Results: Timing of sample collection (early in infection may yield negative results); degree of immunosuppression (more likely positive in severely immunocompromised patients); previous antiviral therapy (may suppress viral load); CSF sample quality and volume; concurrent use of antiretroviral therapy in HIV patients
- Clinical Significance Patterns: Positive result in immunocompromised patient with compatible symptoms = confirmed CMV CNS infection; Positive result with negative blood CMV PCR = CNS-localized infection; Declining viral load on serial testing = favorable treatment response; Rising viral load = treatment failure or resistance; Positive result in immunocompetent patient = unusual presentation requiring investigation
4. Associated Organs
- Primary Organ Systems: Central Nervous System (brain and spinal cord); Meninges (protective membranes); Peripheral nervous system (in polyradiculomyelitis cases)
- Diseases Diagnosed/Monitored: CMV meningitis; CMV encephalitis; CMV ventriculoencephalitis; CMV polyradiculomyelitis; CMV myelitis; CMV retinitis with CNS involvement; Post-transplant CNS infections
- Conditions Associated with Abnormal Results: Advanced HIV/AIDS (CD4 <50 cells/µL); Solid organ transplant recipients; Hematopoietic stem cell transplant recipients; Patients on chronic corticosteroids or immunosuppressive agents; Congenital or primary immunodeficiency disorders; Malignancy-related immunosuppression
- Potential Complications of Active CNS CMV: Permanent neurological damage; Dementia or cognitive impairment; Seizure disorders; Hearing loss; Vision loss if optic nerve involved; Paralysis or motor weakness; Autonomic dysfunction; Hydrocephalus; Increased intracranial pressure; Death if untreated
5. Follow-up Tests
- If Test is POSITIVE: Repeat CSF PCR after 2-4 weeks to assess treatment response and viral load decline; Blood CMV PCR (quantitative) to assess systemic viral load; CSF analysis with cell count, differential, protein, glucose, and culture; Brain MRI with contrast to evaluate for CMV encephalitis or ventriculoencephalitis; Ophthalmologic examination if CMV retinitis is suspected; HIV viral load and CD4 count if HIV status unknown
- If Test is NEGATIVE with High Clinical Suspicion: Repeat lumbar puncture and CSF PCR (early infection may show false negatives); Serum CMV PCR to assess for systemic infection; CSF culture and multiplex viral PCR panel for alternative viral etiologies; HSV and VZV PCR; Bacterial and fungal cultures; CT or MRI brain imaging
- Monitoring During Treatment: CSF PCR every 2-4 weeks during active treatment with ganciclovir, foscarnet, or cidofovir; Serial CSF parameters (repeat lumbar puncture); Blood CMV PCR weekly or every 2 weeks; Clinical neurological assessment; CD4 count monitoring in HIV patients (immune reconstitution with antiretroviral therapy)
- Complementary Tests: Multiplex PCR panel for other viruses (HSV-1/2, VZV, EBV, enterovirus, parechovirus); CSF immunoglobulin levels; Syphilis serology; Tuberculosis testing; Cryptococcal antigen; CSF lactate levels; EEG if seizures suspected
- Post-Treatment Follow-up: CSF PCR 2 weeks after completion of therapy to confirm viral clearance; Monthly blood CMV PCR during suppressive therapy; Ophthalmology follow-up to monitor for CMV retinitis; Neuropsychological testing if cognitive deficits present; Long-term CD4 monitoring in HIV patients to assess immune reconstitution
6. Fasting Required?
- Fasting Requirement: NO - Fasting is not required for this test as it involves cerebrospinal fluid collection via lumbar puncture, not blood draw
- Patient Preparation Instructions: Patient may eat and drink normally prior to procedure; Light meal recommended as full stomach is discouraged before lumbar puncture; Hydration is encouraged; Empty bladder before procedure; Wear comfortable, loose-fitting clothing that can be easily removed; Arrive 10-15 minutes early for registration
- Medications - Important Considerations: Anticoagulants (warfarin, dabigatran, rivaroxaban) - discuss with physician; assess bleeding risk; may require holding dose; Antiplatelet agents (aspirin, clopidogrel) - typically continued but inform provider; NSAIDs - may be held 24-48 hours prior if significant bleeding risk; Regular medications - continue as normal unless specifically instructed otherwise by physician; Notify provider of all medications including supplements
- Pre-Procedure Requirements: Baseline coagulation studies (PT/INR, PTT, platelet count) if on anticoagulation or with bleeding disorder; Brain imaging (CT or MRI) if papilledema or increased intracranial pressure suspected; Informed consent discussion; Review of procedure risks and benefits; Verification of patient identity and site marking per protocol
- Post-Procedure Care: Remain lying flat for 30 minutes to 2 hours post-procedure; Increase fluid intake; Rest for remainder of day; Mild over-the-counter analgesics acceptable for headache or back pain; Report severe headache, fever, stiff neck, or neurological symptoms to healthcare provider immediately; Bandage at puncture site can be removed after 24 hours

How our test process works!